Clinical Trials

Gold Divider 4Col
Clinical Trials

Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.

View All Service Areas

Discover how The Mount Sinai Medical Center can offer you the most advanced and compassionate inpatient and outpatient care.

Institutes, Centers, Programs and Laboratories

The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known.

ELITE Study

A Prospective , Single Blind, Randomized, Multi-Center, Study Comparing the Cypher-ELITE to Cypher Bx VELOCITY Sirolimus-Eluting Stent Systems (ELITE Study).

The ELITE study will evaluate multiple safety and efficacy measures including target lesion revascularization, major adverse cardiac events (MACE) such as death, myocardial infarctions, and stent thrombosis. Additionally, the study population will also allow for analysis on such complex patient groups as diabetics and multi-vessel disease. Additionally, the ELITE study will add to the safety and efficacy data available for drug eluting stents.

  • Principal Investigator

    Pedro R. Moreno
  • Compensation

    N
  • Inclusion

    1.Subjects with coronary artery disease in 1 or 2 blood vessels 2.The subject must be >18 years of age 3.Female of childbearing potential must have a negative pregnancy test within 7 days prior to enrollment 4.Diagnosis of chest pain. 5. Treatment of more than two major coronary arteries. 6.Subject is willing to comply with the specified follow-up evaluation.
  • Exclusion

    1.EKG changes of Myocardial Infarction 2.Prior intervention target blood vessel 3.Left ventricular ejection fraction <25% 4.Impaired renal function 5.Recipient of heart transplant 6.Subject with a life expectancy less than 12 months 7.Allergies to Aspirin, Plavix and Ticlid. 8.Currently participating in an investigational drug or device study 9.Bleeding disorder 10.Subject is either pregnant, a prisoner, mentally incompetent, and/or alcohol or drug abuser 11. Major surgical or interventional procedures within 30 days prior to this study
  • Sponsoring Organization

    Mount Sinai Medical Center
  • Department Name

    MSSM Cardiovascular Institute
  • Contact Information

    Kameswari Vallabhajosyula [Coordinator]
    Mrs.
    kameswari.vallabhajosyula@msnyuhealth.org
    212-241-5696 45696
  • GCO Number

    07-1252
  • IRB Start/End Date

    November 27, 2008 to November 26, 2009

Coming to Mount Sinai?

Directions

Arrive at the Medical Center by car, public transportation and from all area airports.

Find A Faculty Member

Events

Search for Events

Mount Sinai has scheduled events for faculty, physicians, students, staff, and the community. View events by day, week, and month.

(800) MD-SINAI (800) 637-4624

Visit Mount Sinai Queens